Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Ultibro Group
Indacaterol
Novartis
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2021 Revenue in Millions : 584
2020 Revenue in Millions : 623
Growth (%) : -6
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF